Register for email alerts and news feeds:
This journal | BMJ Group
rss
Tobacco Control 2006;15(Supplement 4 ):iv68-iv76; doi:10.1136/tc.2005.014241
Copyright © 2006 by the BMJ Publishing Group Ltd.

RESEARCH PAPER

Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses

John A Francis, Amy K Shea, Jonathan M Samet*

Institute for Global Tobacco Control, Johns Hopkins School of Public Health, Baltimore, Maryland, USA

Correspondence to:
Correspondence to:
Professor Jonathan M Samet
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Suite W6041, Baltimore, MD 21205, USA; jsamet{at}jhsph.edu

Objective: To analyse the statements given by tobacco industry defence witnesses during trial testimonies and depositions in second-hand smoke cases and in parallel, to review criticisms of epidemiology in industry-funded publications in order to identify strategies for discrediting epidemiologic evidence on passive smoking health effects.

Methods: A collection of depositions and trial testimony transcripts from tobacco industry-related lawsuits filed in the United States during the 1990s, was compiled and indexed by the Tobacco Deposition and Trial Testimony Archive (DATTA). Statements in DATTA made by expert witnesses representing the tobacco industry relating to the health effects of passive smoking were identified and reviewed. Industry-supported publications within the peer-reviewed literature were also examined for statements on exposure misclassification, meta-analysis, and confounding.

Results: The witnesses challenged causation of adverse health effects of passive smoking by citing limitations of epidemiologic research, raising methodological and statistical issues, and disputing biological plausibility. Though not often cited directly by the witnesses, the defence tactics mirrored the strategies used in industry-funded reports in the peer-reviewed literature.

Conclusion: The tobacco industry attempted to redirect the focus and dialogue related to the epidemiologic evidence on passive smoking. This approach, used by industry experts in trial testimony and depositions, placed bias as a certain alternative to causation of diseases related to passive smoking and proposed an unachievable standard for establishing the mechanism of disease.

Abbreviations: CIAR, Center for Indoor Air Research; DATTA, Tobacco Deposition and Trial Testimony Archive; EPA, Environmental Protection Agency; ETS, environmental tobacco smoke; IARC, International Agency for Research on Cancer; NHANES, National Health and Nutrition Examination Survey; ORNL, Oak Ridge National Laboratory; OSHA, Occupational Safety and Health Administration

Keywords: tobacco industry; passive smoking; environmental tobacco smoke; ETS


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Narkiewicz, K. (2007). Second-hand smoke--a license to kill due to expire. Nephrol Dial Transplant 22: 1508-1511 [Full Text]  
  • Blanke, D D., Humphrey, H. H III (2006). Putting truth into action: using the evidence for justice. Tobacco Control 15: iv1-iv3 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.